Literature DB >> 12165083

Profiles of cell-to-cell interaction of Mycobacterium intracellulare-induced immunosuppressive macrophages with target T cells in terms of suppressor signal transmission.

K Ogasawara1, H Tomioka, T Shimizu, C Sano, H Kawauchi, K Sato.   

Abstract

Previously, we have found that immunosuppressive macrophages (M(phi)s) induced by Mycobacterium intracellulare-infection (MI-M(phi)s) required cell contact with target T cells to express their suppressor activity against concanavalin A (Con A)-induced T cell mitogenesis. In this study, we examined the profiles of cell-to-cell interaction of MI-M(phi)s with target T cells. First, MI-M(phi)s displayed suppressor activity in an H-2 allele-unrestricted manner, indicating that MHC molecules are not required for cell contact. The suppressor activity of MI-M(phi)s was reduced markedly by paraformaldehyde fixation or treatment with cytochalasin B or colchicine, indicating that vital membrane functions are required for their suppressor activity. Secondly, the suppressor activity of MI-M(phi)s was independent of cell-to-cell interaction via CD40 ligand/CD40 and M(phi)-derived indoleamine 2,3-dioxygenase, which causes rapid degradation of tryptophan in T cells. Thirdly, precultivation of splenocytes with MI-M(phi)s, allowing cell-to-cell contact, reduced Con A- or anti-CD3 antibody-induced mitogenesis but not phorbol myristate acetate/calcium ionophore A23187-elicited proliferation of T cells. In addition, co-cultivation of T cells with MI-M(phi)s caused marked changes in profiles of the tyrosine phosphorylation of 33 kDa, 34 kDa and 35-kDa proteins and, moreover, the activation of protein kinase C and its translocation to the cell membrane. It thus appears that suppressor signals of MI-M(phi)s, which are transmitted to the target T cells via cell contact, principally cross-talk with the early signalling events before the activation of PKC and/or intracellular calcium mobilization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165083      PMCID: PMC1906442          DOI: 10.1046/j.1365-2249.2002.01890.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  A novel functional interaction between Vav and PKCtheta is required for TCR-induced T cell activation.

Authors:  M Villalba; N Coudronniere; M Deckert; E Teixeiro; P Mas; A Altman
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

Review 2.  Proximal protein tyrosine kinases in immunoreceptor signaling.

Authors:  S Latour; A Veillette
Journal:  Curr Opin Immunol       Date:  2001-06       Impact factor: 7.486

3.  Suppressor adherent cells in human tuberculosis.

Authors:  J J Ellner
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

4.  Potentiation of lymphokine-activated killer cell differentiation and lymphocyte proliferation by stimulation of protein kinase C or inhibition of adenylate cyclase.

Authors:  S K Beckner; W L Farrar
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

Review 5.  Integration of T cell receptor-dependent signaling pathways by adapter proteins.

Authors:  J L Clements; N J Boerth; J R Lee; G A Koretzky
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

6.  CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms.

Authors:  T Kuroiwa; E G Lee; C L Danning; G G Illei; I B McInnes; D T Boumpas
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

7.  A novel isoform of the low molecular weight phosphotyrosine phosphatase, LMPTP-C, arising from alternative mRNA splicing.

Authors:  P Tailor; J Gilman; S Williams; T Mustelin
Journal:  Eur J Biochem       Date:  1999-06

8.  Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response.

Authors:  E Giacomini; E Iona; L Ferroni; M Miettinen; L Fattorini; G Orefici; I Julkunen; E M Coccia
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

9.  Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma.

Authors:  C K Edwards; H B Hedegaard; A Zlotnik; P R Gangadharam; R B Johnston; M J Pabst
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

10.  Role of CD40 ligand in Mycobacterium avium infection.

Authors:  T Hayashi; S P Rao; P R Meylan; R S Kornbluth; A Catanzaro
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

View more
  5 in total

1.  The role of B7 molecules in the cell contact-mediated suppression of T cell mitogenesis by immunosuppressive macrophages induced with mycobacterial infection.

Authors:  T Shimizu; C Sano; H Tomioka
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

2.  Comparative studies on the roles of mediator molecules in expression of the suppressor activity of Mycobacterium avium complex-induced immunosuppressive macrophages against T cell and B cell mitogenic responses.

Authors:  S Cai; T Shimizu; H Tomioka
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

Review 3.  Characteristics of suppressor macrophages induced by mycobacterial and protozoal infections in relation to alternatively activated M2 macrophages.

Authors:  Haruaki Tomioka; Yutaka Tatano; Win Win Maw; Chiaki Sano; Yuichi Kanehiro; Toshiaki Shimizu
Journal:  Clin Dev Immunol       Date:  2012-05-15

4.  Aldose reductase participates in the downregulation of T cell functions due to suppressor macrophages.

Authors:  Toshiaki Shimizu; Yutaka Tatano; Haruaki Tomioka
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

5.  Unique macrophages different from M1/M2 macrophages inhibit T cell mitogenesis while upregulating Th17 polarization.

Authors:  Yutaka Tatano; Toshiaki Shimizu; Haruaki Tomioka
Journal:  Sci Rep       Date:  2014-02-20       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.